Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (Nasdaq:EGRX)
today announced its financial results for the transitional three-month
period ended December 31, 2014 (the “stub period”). This stub period
resulted from the previously-announced change in Eagle’s year end
from September 30 to December 31.
for 2015/2/17 - Eagle Pharmaceuticals, Inc. Reports Financial Results for Three Month Period Ended December 31, 2014 investment picks